AG13958

Please request pricing for this article.
Request Pricing

Item number	Size	Manual	Delivery time	Price
SYN-1004-M001	1 mg	-	3 - 9 business days*	329.00€
SYN-1004-M005	5 mg	-	3 - 9 business days*	652.00€
SYN-1004-M010	10 mg	-	3 - 9 business days*	1,001.00€
SYN-1004-M050	50 mg	-	3 - 9 business days*	-
SYN-1004-M100	100 mg	-	3 - 9 business days*	-

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Soluble in DMSO. AG13958 is a VEGF inhibitor that was in clinical development for treatment of... more

Close menu

Product information "AG13958"

Soluble in DMSO. AG13958 is a VEGF inhibitor that was in clinical development for treatment of age-related macular degeneration (AMD). The drug displays low water solubility and so far in trials delivery has been difficult needing direct injection to be truly effective and it varied by the species used because of species specific differences in eye circulation and vascularization. As a VEGF inhibitor AG13958 was targeted to FLT/TYK receptor inhibition. Target: FLT - TYK , Kinase Group: RTK , Substrate: Tyrosine

Keywords:	AG-13958
Supplier:	SYNkinase
Supplier-Nr:	1004

Properties

Application:	FLT/TYK receptor inhibitor
MW:	467,5 D
Formula:	C26H22FN7O
Purity:	>95%
Format:	Solid

Database Information

CAS :	319460-94-1\| Matching products
KEGG ID :	K05096 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+20°C (International: +20°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

View product citations for antibody 1004 on CiteAb

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "AG13958"

Write a review